CGBio Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 140

Employees

  • Latest Deal Type
  • Buyout/​LBO
  • (Upcoming)

  • Latest Deal Amount
  • $689M

  • Investors
  • 2

CGBio General Information

Description

Manufacturer of regenerative medicine products intended to enhance the quality of life for patients with spinal disorders and wound management. The company is engaged in the development of medicines for a spectrum of spinal disorders and wound management, including a comprehensive portfolio of allograft and synthetic bone grafts, spinal implants, and good manufacturing practices (GMP) grade growth factors, providing clients with medicines that address medical needs and are convenient for use in clinical settings.

Contact Information

Website
www.cgbio.co.kr
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Corporate Office
  • 1, Sangwon 12-gil
  • Seongdong-gu
  • Seoul, 04349
  • South Korea
+82
Primary Industry
Pharmaceuticals
Other Industries
Therapeutic Devices
Vertical(s)
Corporate Office
  • 1, Sangwon 12-gil
  • Seongdong-gu
  • Seoul, 04349
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CGBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Buyout/LBO $689M Upcoming Generating Revenue
2. Grant 01-Jan-2019 Completed Generating Revenue
1. Grant 01-Jan-2014 $2.84M Completed Generating Revenue
To view CGBio’s complete valuation and funding history, request access »

CGBio Patents

CGBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026205936-A1 Method for preparing collagen slurry, and hemostatic kit comprising same Pending 24-Mar-2025
WO-2026192403-A1 Wound dressing composition comprising hemostatic aid and method for preparing same Pending 14-Mar-2025
WO-2026079852-A1 Biomatrix and manufacturing method therefor Pending 07-Oct-2024
WO-2026054593-A1 Fish-derived acellular dermal matrix and preparation method therefor Pending 06-Sep-2024
WO-2026019107-A1 Lifting member for plastic surgery and manufacturing method therefor Pending 19-Jul-2024
To view CGBio’s complete patent history, request access »

CGBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CGBio Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ministry of Trade, Industry and Resources Limited Partner
Daewoong Pharmaceutical Corporation Majority
To view CGBio’s complete investors history, request access »

CGBio Investments & Acquisitions (8)

CGBio’s most recent deal was a Merger/Acquisition with DNC Aesthetics. The deal was made on 21-Jul-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
DNC Aesthetics 21-Jul-2025 Merger/Acquisition Personal Products
Litian Biotechnology 30-Apr-2025 Joint Venture Other Devices and Supplies
CG MedTech 30-Oct-2024 PIPE Surgical Devices
CG MedTech 27-Feb-2024 PIPE Surgical Devices
CG MedTech 01-Dec-2023 Secondary Transaction - Private Surgical Devices
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

CGBio Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
M.base Seongnam-si, South Korea 2017
DNC Aesthetics Seoul, South Korea 2001

CGBio FAQs

  • When was CGBio founded?

    CGBio was founded in 2006.

  • Where is CGBio headquartered?

    CGBio is headquartered in Seoul, South Korea.

  • What is the size of CGBio?

    CGBio has 140 total employees.

  • What industry is CGBio in?

    CGBio’s primary industry is Pharmaceuticals.

  • Is CGBio a private or public company?

    CGBio is a Private company.

  • What is the current valuation of CGBio?

    The current valuation of CGBio is .

  • What is CGBio’s current revenue?

    The current revenue for CGBio is .

  • Who are CGBio’s investors?

    Ministry of Trade, Industry and Resources and Daewoong Pharmaceutical have invested in CGBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process